Last reviewed · How we verify

NCT02058654

A Clinical Study to Investigate the Effects of Creatine Supplementation on Muscle Energetics and Cognitive Function in Young Healthy Male Athletes and an Ageing Population

Completed Phase 1 Last updated 23 March 2018
What this trial tests

Phase 1 trial testing Creatine in Nutritional Status in 30 participants. Completed in 24 June 2014.

Timeline
1 December 2013
Primary endpoint
1 June 2014
24 June 2014

Quick facts

Lead sponsorGlaxoSmithKline
PhasePhase 1
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposebasic science
Enrollment30
Start date1 December 2013
Primary completion1 June 2014
Estimated completion24 June 2014
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

GlaxoSmithKline — full company profile →

Who can join

Adults 18 to 70, any sex, with Nutritional Status. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will examine the impact of creatine supplementation on muscle function and cognitive performance in young and older subjects.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Creatine

Trials testing the same drug.

Other recruiting trials for Nutritional Status

Currently open trials in the same condition.

Other GlaxoSmithKline trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02058654.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing